Image

Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries

Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries

Recruiting
18 years and older
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

This study will test whether using ultrasound imaging within blood vessels during minimally invasive treatment of leg arteries in patients with peripheral artery disease leads to better clinical outcomes.

Description

This is a U.S. prospective multicenter randomized controlled trial to evaluate the clinical outcomes of Intravascular ultrasound (IVUS) guided Femoropopliteal (FP) endovascular intervention in patients with symptomatic peripheral artery disease (PAD) (Rutherford class 2-5).

Eligibility

Inclusion Criteria:

  • 1\. Age ≥18 years
  • Symptomatic FP PAD with angiographic evidence of \>50% stenosis
  • Candidates for endovascular therapy

Exclusion Criteria:

  • Prior intervention at the target lesion within 6 months
  • Enrolled in a Lower Extremity Peripheral Artery Disease Interventional (drug or device) trial

Study details
    Peripheral Arterial Disease
    Femoropopliteal Disease

NCT07353905

Baylor Research Institute

31 January 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.